Global Neutron Capture Therapy of Cancer Market Insights, Forecast to 2034
Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical
Publisher : MRA | Format : PDF
Global Neutron Capture Therapy of Cancer Market Insights, Forecast to 2034
Neutron capture therapy (NCT) is a type of radiotherapy for treating locally invasive malignant tumors such as primary brain tumors, recurrent cancers of the head and neck region, and cutaneous and extracutaneous melanomas. It is a two-step processfirst, the patient is injected with a tumor-localizing drug containing the stable isotope boron-10 (10B), which has a high propensity to capture low energy "thermal" neutrons. The neutron cross section of 10B (3,837 barns) is 1,000 times more than that of other elements, such as nitrogen, hydrogen, or oxygen, that occur in tissue. In the second step, the patient is radiated with epithermal neutrons, the sources of which in the past have been nuclear reactors and now are accelerators that produce higher energy epithermal neutrons.
Market Analysis and InsightsGlobal Neutron Capture Therapy of Cancer Market
Global Neutron Capture Therapy of Cancer market is expected to reach to US$ 116 million in 2023, with a positive growth of %, compared with US$ 84 million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, Neutron Capture Therapy of Cancer industry is evaluated to reach US$ 248 million in 2033. The CAGR will be 13.5% during 2023 to 2033.
Globally, Neutron Capture Therapy of Cancer key companies include TAE Life Sciences, RaySearch, Neutron Therapeutics, International Particle Therapy, Southern TOHOKU Hospital Group and Neuboron Medtech, etc. TAE Life Sciences, RaySearch, Neutron Therapeutics are top 3 players and held % share in total in 2022.
When considering the consumption regions, % revenue of Neutron Capture Therapy of Cancer were sold to North America, Europe and Asia Pacific in 2022. Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2023 to 2033 and the share will be % in 2033. Moreover, China, plays a key role in the whole Neutron Capture Therapy of Cancer market and estimated to attract more attentions from industry insiders and investors.
Neutron Capture Therapy of Cancer can be divided into Thermal Beam and Epithermal Beam, etc. Thermal Beam is the mainstream product in the market, accounting for % revenue share globally in 2022 and the proportion will be % in 2033.
Neutron Capture Therapy of Cancer is widely used in various fields, such as Brain Tumor, Extracranial Tumor and Others,, etc. Brain Tumor provides greatest supports to the Neutron Capture Therapy of Cancer industry development. In 2022, global % revenue of Neutron Capture Therapy of Cancer went into Brain Tumor filed and the proportion will reach to % in 2033.
Report Covers
This report presents an overview of global Neutron Capture Therapy of Cancer market from 2018 to 2033, aiming to help readers to get a comprehensive understanding of global Neutron Capture Therapy of Cancer market with multiple angles. Items like regional revenue from 2018 to 2033 and companies’ revenue and gross margin from 2018 to 2023 are analyzed. In addition, revenue of product type and application in each region from 2018 to 2033 are also highlighted.
Companies, Type, Application and Regions Listed in the Report
TAE Life Sciences
RaySearch
Neutron Therapeutics
International Particle Therapy
Southern TOHOKU Hospital Group
Neuboron Medtech
Segment by Type
Thermal Beam
Epithermal Beam
Brain Tumor
Extracranial Tumor
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue analysis from 2018 to 2033
Chapter 3Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Product revenue analysis by type from 2018 to 2033 globally
Chapter 5Product revenue analysis by application from 2018 to 2033 globally
Chapter 6Product revenue analysis by type and application from 2018 to 2033 in US & Canada. Product revenue analysis of each country in US & Canada from 2018 to 2033
Chapter 7Product revenue analysis by type and application from 2018 to 2033 in Europe. Product revenue analysis of each country in Europe from 2018 to 2033
Chapter 8Product revenue analysis by type and application from 2018 to 2033 in China. Product revenue analysis of China from 2018 to 2033
Chapter 9Product revenue analysis by type and application from 2018 to 2033 in Asia (excluding China). Product revenue analysis of each country in Asia (excluding China) from 2018 to 2033
Chapter 10Product revenue analysis by type and application from 2018 to 2033 in Middle East, Africa and Latin America. Product revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2033.
Chapter 11Companies’ outline, covering company’s basic information, major business, Neutron Capture Therapy of Cancer introduction, etc. Neutron Capture Therapy of Cancer Revenue and Gross Margin of each company from 2018 to 2023
Chapter 12MRAResearch’s Conclusions of Neutron Capture Therapy of Cancer
Chapter 13Methodology and Data Sources adopted by MRAResearch
Market Analysis and InsightsGlobal Neutron Capture Therapy of Cancer Market
Global Neutron Capture Therapy of Cancer market is expected to reach to US$ 116 million in 2023, with a positive growth of %, compared with US$ 84 million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, Neutron Capture Therapy of Cancer industry is evaluated to reach US$ 248 million in 2033. The CAGR will be 13.5% during 2023 to 2033.
Globally, Neutron Capture Therapy of Cancer key companies include TAE Life Sciences, RaySearch, Neutron Therapeutics, International Particle Therapy, Southern TOHOKU Hospital Group and Neuboron Medtech, etc. TAE Life Sciences, RaySearch, Neutron Therapeutics are top 3 players and held % share in total in 2022.
When considering the consumption regions, % revenue of Neutron Capture Therapy of Cancer were sold to North America, Europe and Asia Pacific in 2022. Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2023 to 2033 and the share will be % in 2033. Moreover, China, plays a key role in the whole Neutron Capture Therapy of Cancer market and estimated to attract more attentions from industry insiders and investors.
Neutron Capture Therapy of Cancer can be divided into Thermal Beam and Epithermal Beam, etc. Thermal Beam is the mainstream product in the market, accounting for % revenue share globally in 2022 and the proportion will be % in 2033.
Neutron Capture Therapy of Cancer is widely used in various fields, such as Brain Tumor, Extracranial Tumor and Others,, etc. Brain Tumor provides greatest supports to the Neutron Capture Therapy of Cancer industry development. In 2022, global % revenue of Neutron Capture Therapy of Cancer went into Brain Tumor filed and the proportion will reach to % in 2033.
Report Covers
This report presents an overview of global Neutron Capture Therapy of Cancer market from 2018 to 2033, aiming to help readers to get a comprehensive understanding of global Neutron Capture Therapy of Cancer market with multiple angles. Items like regional revenue from 2018 to 2033 and companies’ revenue and gross margin from 2018 to 2023 are analyzed. In addition, revenue of product type and application in each region from 2018 to 2033 are also highlighted.
Companies, Type, Application and Regions Listed in the Report
By Company
TAE Life Sciences
RaySearch
Neutron Therapeutics
International Particle Therapy
Southern TOHOKU Hospital Group
Neuboron Medtech
Segment by Type
Thermal Beam
Epithermal Beam
Segment by Application
Brain Tumor
Extracranial Tumor
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter Outline
Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue analysis from 2018 to 2033
Chapter 3Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Product revenue analysis by type from 2018 to 2033 globally
Chapter 5Product revenue analysis by application from 2018 to 2033 globally
Chapter 6Product revenue analysis by type and application from 2018 to 2033 in US & Canada. Product revenue analysis of each country in US & Canada from 2018 to 2033
Chapter 7Product revenue analysis by type and application from 2018 to 2033 in Europe. Product revenue analysis of each country in Europe from 2018 to 2033
Chapter 8Product revenue analysis by type and application from 2018 to 2033 in China. Product revenue analysis of China from 2018 to 2033
Chapter 9Product revenue analysis by type and application from 2018 to 2033 in Asia (excluding China). Product revenue analysis of each country in Asia (excluding China) from 2018 to 2033
Chapter 10Product revenue analysis by type and application from 2018 to 2033 in Middle East, Africa and Latin America. Product revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2033.
Chapter 11Companies’ outline, covering company’s basic information, major business, Neutron Capture Therapy of Cancer introduction, etc. Neutron Capture Therapy of Cancer Revenue and Gross Margin of each company from 2018 to 2023
Chapter 12MRAResearch’s Conclusions of Neutron Capture Therapy of Cancer
Chapter 13Methodology and Data Sources adopted by MRAResearch